Friday, September 6, 2019

Annotated Biblography Essay Example for Free

Annotated Biblography Essay Kristen E. Van Vonderen, M. S. , William Kinnally, Ph. D. (2012), â€Å"Media Effects on Body Image: Examining Media Exposure in the Broader Context of Internal and Other Social Factors†. Volume 14, Issue 2. 41-57. American Communication Journal. Summary: Vonderson and Kinnally’s article discusses the influence media has on women today and the way they see themselves. Being â€Å"overweight† has such negative stigmatism to it that women who are considered to be overweigh feel as though they are unlovable or unsuccessful because they dont look like the women in magazines. They touch on the subject of the influence from parents and peers. Parents who comment on their child’s physical appearance convey body image norms that could lead to negative association with body shape. In the article they also talk about internal influences such as self-esteem and how, in part, it is a reflection of the opinion others hold of you. Analysis: Vonderson and Kinnally’s approach to informing us about how women are portrayed in magazines is both informative and surprising. I, myself being a young women was more than aware of the issue with body image and the media. I personally have thought less of myself after looking through a magazine or watching a movie because of how thin and beautiful those women are. But I was not aware of the many causes that influence women into thinking so negatively. Reflection: This particular article was very informative and helpful towards my research paper topic because it was exactly what I am writing about. Going into this project, I thought I knew quite a bit of information on this topic, but now reading these articles I realize that there is much more to the influence media has on women than I had imagined. Gemma Lopez- Guimera, Micheal P. Levine, David Sanchez-Carracedo, Jordi Fauquet. (2010),† Influence of Mass Media on Body Image and Eating Disordered Attitudes and Behavior in Females: A Review of Effects and Processes†. Media Psychology, 13:387– 416. Print Summary: This article reviews research on the effects of television and magazines on body image and on disordered eating attitudes and behaviors in females. Evidence from different types of studies in the fields of eating disorders, media psychology, health psychology, and mass communication indicates that mass media are an extremely important source of information and reinforcement in relation to the nature of the thin beauty ideal, its importance, and how to attain it. Although considerable research remains to be done, evidence is accumulating that repeated exposure to media and to both direct and indirect (via medias effects on peers, parents, coaches, physicians, etc. ) pressures from media to be thin constitute risk factors for body dissatisfaction, concerns over weight and disordered eating behaviors in adolescent girls and young women. Analysis: I found this article to be both credible and reliable mainly on the fact that it’s research was conducted professionally. The multiple authors of this article are credible because they are head departments of psychology, clinical and health psychology, psychobiology, and methodology of health sciences all from admirable universities all over the world. Reflection: This article help shapes the arguments in my research paper. My research paper is on the topic of mass media and its influence on society and with an article that focuses just on the female aspect of it, it will really help my arguments. So, J. and Nabi, R. (2013), Reduction of Perceived Social Distance as an Explanation for Medias Influence on Personal Risk Perceptions: A Test of the Risk Convergence Model. Human Communication Research, 39: 317–338. Print Summary: The aim of this study was to develop the Perceived Parental Media Mediation Scale (PPMMS). in an initial test of this model, 500 undergraduate students at the University of California, Santa Barbara, participated in an experiment. Participants were exposed to entertainment clips that either portrayed a main character who is diagnosed with a sexually transmitted disease or thinks he/she might have caught an STD and gets scared of testing for it. Overall, the risk convergence model received solid support from the data, with all paths emerging as significant except for the link between perceived realism and social distance. Reduction of social distance completely mediated the relationship between identification, transportation and personal risk perceptions, thus suggesting social distance as a valid causal mechanism of the process involving the two variables. Analysis: This article is credible because studies were conducted at multiple universities such as University of Georgia and UC Santa Barbara by experts in the Department of Communications. I found this article to be non biased based on the fact that they had conducted numerous experiments and tests on a large number of students and still found that their risk perception was influenced by the media. Reflection: I found this article to be very helpful with my research paper, being that it was a rather long article with more than enough information explaining medias influence on personal risk perception.

Ethical Decisions Essay Example for Free

Ethical Decisions Essay Every individual is faces with ethical decisions every day in both their personal and professional lives. To avoid making unethical decisions, one must know what leads to poor decision making. Once a person knows what leads to the poor decision, they must find ways to resist making an unethical act. A person cannot make the right choice if they do not know how to avoid it. A leader must also know how to inspire ethical decisions within their staff. This paper covers ways to avoid making poor decisions and ways to making ethical ones. Poor Decision Characteristics While there are many ways one can be ethical, Mallor, Barnes, Bowers, Langvardt suggest there are three essential traits one makes when a poor decision is made (1966/2010, p. 115). The fist common mistake of poor decision-making is when one forgets the goal that was previous set by him or herself or the organization. A person or the organization must keep all of their goals in mind when making decision, and many times individuals forget these goals. Overconfidence is another trait of poor decision-making. One aspect of overconfidence being that nobody will notice a little mistake made for correction later. For example, a manager may take a few dollars from the business expecting to put it back later and then a few more and later still more. However tomorrow never comes and before long, that first few dollars turns into hundreds or thousands. In the organization of my employment a small loan company as well as the owners stock car team on the side exists. The loan company sponsors the racing, and a year ago, the organization moved from the Midwest to the heart of NASCAR country. Once the owner arrived, he decided to buy the best equipment for the race team using funds from the loan company. While the spending spree may have been ok in the past, the owner did not take into account that need of hiring and training of new employees. When the new employees made poor lending decisions, combined with his spending, the organization almost went bankrupt. The other aspect of overconfidence is confirmation bias or â€Å"we  must be doing things the right way because all has gone well in the past† (Mallor et al., 1966/2010, p. 116). The overconfidence shows in the example of the overspending by the owner of the organizations statement: â€Å"Oh, it will all work out, because it always has†. The last trait of poor decision-making occurs when the issues are too complex and not realized for their complexity. Individuals may not realize the complexity of the issue and underestimate the issue. In the lending business, should we as an organization not know the laws of each state when it comes to lending, we can face serious legal issues should we make a loan to a resident of a state in which short term lending, such as we do, is illegal. Resisting Unethical Acts Resisting unethical acts, many times, is easier said than done. In order to do so, a person must first recognize that what they are about to do is unethical (Mallor et al., 1966/2010, p. 116). The first way to avoid making an unethical decision is to buy some time before acting. An individual must take some time, analyze the situation, and if need be, find other ways to accomplish the task at hand without being unethical. The next tactic is to seek out help from a mentor or support group. While an individual may not have the ethical solution to a problem at hand, many times others will. There have been many times when I have sought the advice of others prior to making a decision, which I think may be unethical. Using the previous example of making a loan to someone in a state in which it is illegal, I may ask the advice of a co-worker before I make the loan. The last way to resist making an unethical act is to find a better solution in which everyone wins. This goes hand in hand with one buying some time before acting upon an unethical act. Analyzing the situation, and getting all the facts may lead to a decision in which one makes an ethical decision while meeting the requirements of the direction one has been given. Leading Ethically When leading other individuals, it is imperative that one be ethical themselves, in order to lead ethically. A person, who is unethical, is going to inspire unethical behaviors in others. When members of an organization see that nothing happens to their leaders, others will fall  into the same unethical behavior and rationalize that what they are doing is ok as well (Mallor et al., 1966/2010, p. 119). Leaders must set the example of ethical behavior for others. Leaders must also communicate ethical values of the organization to the staff. How can an individual know what they are doing is unethical in the eyes of the organization, if they do not know what is expected of them? The leader must continually communicate to the staff and remind them of what is ethical behavior. Another way to lead other ethically is to reinforce ethical behavior in the staff. When a leader sees an ethical decision made by a staff member, recognize their action. This will help that employee continue to make the right decision, and show others what is ethical behavior. Conclusion In order to be ethical, one must know what makes ethical and unethical decisions in their lives. Recognizing what makes an unethical decision, and ways to avoid making them, will help one to makes the right choice. Analyzing the situation, weighing other options and alternatives will help one to make an ethical decision. For a leader, these tools will also help their staff make ethical decisions as well. References Mallor, J., Barnes, A. J., Bowers, T., Langvardt, A. W. (2010). Business law; The ethical, global, and e-commerce environment (14th ed.). New York: McGraw-Hill Irwin. (Original work published 1966)

Thursday, September 5, 2019

Current Strategies And Business Model Marketing Essay

Current Strategies And Business Model Marketing Essay This study is considered about the AstraZeneca Plc Company by applying more strategies to their business growth. In this review it considered the key opportunities and challenges of AstraZeneca Plc Company for business growth by using more strategies. This study is required to increase their research and quality conscious of medicines. It analysis the internal organization to produce more quality and cost conscious of the product and also it analysis the strength and weakness of the company. It leads to more growth, sales and revenue of pharmaceutical industry. Table of Contents S.No. Particulars Page No. 1. Introduction 3 2. About AstraZeneca 3 3. Task I 4 4. Task II 11 5. Analysis of AstraZeneca 16 6. Recommendations 16 7. Conclusion 17 8. References 17 Introduction: The pharmaceutical industries are leads to more growth in the new product development. Nowadays there are more new medicines and drugs are created by the biological researchers. There is more business strategy and marketing strategies are used to develop their market and demand in the pharmaceutical industry. Here AstraZeneca Company has recommended to applying the more strategy to this study. In this study we are using descriptive research to this review. For this study, the reference has taken from various sources like journal, article, net links, magazines, textbooks etc. About Astrazeneca: AstraZeneca is one of the leading pharmaceutical company in the world. The company has formed in the year 1999, after the merger of Swedens Astra AB and UKs Zeneca Group plc. David Brennan is the CEO of the company. The head quarters of the company are in London, UK. The AstraZeneca has come across number of new product into the market. AstraZeneca is one of the Third largest pharmaceutical company in the world. There is largest Research Development Centre has formed and it invested about 16 million for every day. The research and development has produced lot of new product for cancer, cardiovascular, gastrointestinal etc.. after the company has merged and it produces a lot of new products and medicines for the patients and doctors. It has aimed to produce a great quality medicine and to innovate more medicines for lot of diseases. And it have objective to improve corporate responsibility to the society and shareholder. http://www.astrazeneca.co.uk/about-us/ (date: 11-01-2010, time: 3.15p.m) There are 66000 employees are working in the AstraZeneca among Europe, Asia, US, Africa etc. The AstraZeneca has 29 manufacturing Sites among the 19 countries. In 2006 the company has achieved $26.5 billion of over all profit. In 2008 the company has achieved and improved $31.5 billion profit. http://www.astrazeneca.co.uk/about-us/keyfacts?itemId=4142279nav=yes (date: 11-01-2010, time: 3.35p.m) TASK I Challenges faced by the AstraZeneca: The AstraZeneca is a largest pharmaceutical company in the world. It works around 100 countries in the world. There are more competitor for pharmaceutical industry. The competitors are Johnson Johnson, merek co, Novarties, Pfizer etc.. the competitor are in world level. So the company has compete world wide, and it challenges to other competitor in new product and development and research. There is more challenges the company has faced by the other outer environment. So the AstraZeneca has develop new medicines for cancer and other diseases. It must aim to give pain relief to the society. http://www.computing.co.uk/computing/news/2255053/case-study-astrazeneca (date: 11-01-2010, time: 4.12p.m) The AstraZeneca has innovate new products and it provide drug pipeline for cancer, cardiovascular and other diseases. So it aims to reduce the cost and it improve drug pipeline for challenging the competitor circle. AstraZeneca has improved its challenges by the way of reducing the cost of medicines and improving the drug pipeline for various diseases. They increase their research and Development centre to the world and it increase product innovation in medical field. Their vision to increase their market to world wide and innovation of great medicines and it must increase the stakeholder value. Mostly AstraZeneca research development is in Sweden, U.K and U.S. because there is more drugs and raw material has available in the particular place. And also they has more talented person in a biological fields. Strategic Research and Development Issues for challenging competitor: The RD manager is only the responsible for the suggesting and implementing the new medicines for the diseases and it must increase the drugs pipeline for the patients. They are improving their new product development by merging the RD department and technologies. The RD managers Job includes: Choosing among alternative new technology to use within the AstraZeneca pharmaceutical company, Development new methods of embodying the new technology in new products and processes and It deploying resources so that the new technology and medicines can be successfully implemented. Research Development Intensity: The company must make available the resources necessary for effective research and development. The AstraZeneca has spend around $3.9 billion for its research and development. The AstraZenecas R D Intensity is a principal means of gaining market share in global competition. So the R D department has focused the drug pipelines for different diseases and it give pain relief to the patients. The research and development has providing more innovative medicine for the patients to give more effective protection for the diseases. Technology Competence: The technology competence is used for both development and technology development in the R D department. The AstraZeneca has more technology to improve its each drugs pipeline to lead the pharmaceutical market. The R D department has improve their technology development for the growth full product of Arimidex, Crestor, Nexium, Seroquel, Symbicort etc., the product which develop in R D department for cancer, cardiovascular, gastreointestinal diseases, asthma and chronic obstructive pulmonary diseases etc., So it have the more technology competence for leading the market. http://www.astrazeneca.co.uk/about-us/keyfacts?itemId=4142279nav=yes (date: 11-01-2010, time: 6.19p.m) Technology Transfer: The Astra and Zeneca pharmaceutical company has merging together for improving its R D department and innovation of medicines for disease. So it transfers the technologies to improve the research and development process of each company. The technology transfer has given more challenges towards competitor of other pharmaceutical industry. Research and Development Mix: The R D mix has includes everything that would help to sales, quality control, different medicines and technology development of the AstraZeneca pharmaceutical industry. The company has increase its growth of new product and at the same time it maintain quality control of the medicines. The AstraZeneca R D development has got license to innovation of new medicines for the patients and it has intellectual property rights towards its new products. The R D department has maintain more valuable quality control from biological lab with using effective technologies, sales growth, technical laboratories, development of biological labs and more research information of medicines etc.. Strategic Marketing Challenges: The AstraZeneca Companys marketing manager should be focus the customer wants and product cost. Here the marketing manager must introduce the market position and segmentation, marketing mix and the product life cycle for facing leading competition among the world. Market position and Segmentation: This pharmaceutical industry has focus the hospital and patients who are really affected by the diseases, for new research development and it must increase the focused sales among competitors. The AstraZeneca has increased its sales in selected areas. The market has segmented by the new product and new medicines for the patients. Marketing Mix: The marketing mix is like 4 Ps. Promotion, Price, Place, Product are the marketing mix. The AstraZeneca product has more competition, and it have marketing mix to improve the quality and reducing the cost of medicines, which have the suitable place to sell the medicines to the customer. Product life cycle: AstraZeneca has a product life cycle. In 1999 the Astra and Zeneca Pharmaceutical company has merging and it has a introduction stage of the medicine. In 2000 it has an effective growth towards its medicines especially the product of Arimidex, Crestor, Nexium, Seroquel, Symbicort are have efficient growth. After some period it reached the maturity period and in summer time it has a declining stage of the product. This pharmaceutical company has product life cycle, it depends upon the environment and competitor. If it have various new product development means it have more maturity period of this laboratory industry. Source: Philip kotler Gary Armstrong, Principle of Marketing, Prentice Hall of India, 2007. (date: 10-01-2010, time: 7.13p.m) Key Opportunities of AstraZeneca: The Astra Zeneca has innovate more product and merging with other leading pharmaceutical company for developing more new product and medicines for leading future market among competitor. The AstraZeneca has developing its more valuable new product development and improve drugs pipelines. There is using more technologies and using developing more biological labs for developing its new medicines for the product. http://www.independent.co.uk/news/business/the-player-tom-mckillop-chief-executive-of-astrazeneca-creating-the-right-chemistry-1130990.html (date: 11-01-2010, time: 5.33p.m) Opportunities in Research and Development: There is more opportunities for providing new product and medicines to the customer from merging the pharmaceutical company and other biological labs. There are 22000 employees and they were expert in biological medicines are working research and development field. So they able to dedicate more new products and medicines to the rare diseases and it able increase its sales growth. AstraZeneca has improved its new pharmaceutical product of its continuous process. It must build more biological and innovation activities towards its new medicines. The AstraZeneca laboratories have more building capabilities towards its biological labs and build to research in new medicines from agri-chemical industries. This pharmaceutical industry has very talented in biological laboratories and agricultural chemical business for new medicines. So it have more valuable resources and talented employees in biological industries for the process of future development. This deliver that it develops more opportunities for its continuous growth in new product development and sales growth. Sustainable development of AstraZeneca: AstraZeneca has focus to sustain the continuous new product development. AstraZeneca has improved its research and development centre to the world wide for it sustain to increase its new medicines and innovation activities in pharmacy industry. Economic: The pharmaceutical industrial has impact on economic for increasing its economic value from its new products. So AstraZeneca Plc Company has more depended upon the economic and also in 2004 it increases its economic growth to the country. It has more opportunity to improve its economic development of the new product. Social: AstraZeneca has more value in social responsibilities and to give effective and protected medicine to the patients. So it has a impact in social and other things among the pharmaceutical company. Environment: The Company has environment impact towards its new medicines and research in biological industry. The environment should have the awareness about the diseases and new medicines of its protection. So the AstraZeneca has impact and opportunity in environment level of its new product development. Krishnamoorthy, Environmental Management, published by PHI, 2006. (date: 10-01-2010, time:8.23p.m) TASK II Internal and Organizational Analysis of AstraZeneca Pharmaceutical Industries: It must look at the environment, which AstraZeneca has to face in the market and the opportunities and threats that arise from it. It has an analysis towards its internal and organizational factors to improving its efficiency among competitor in world wide. The organization is depending upon the strength weakness of organization and it turned as opportunity for future. Historical: The AstraZeneca company has more sales after the period of 1999. Because the two pharmaceutical company has merging together and it gave a lot of new products and researches to the society. It 2006 the sales growth is $26.5 billion and in 2008 the sales growth has come around $31.5 billion. The companies profit also increases and it beyond its growth level. After 2008 only it became a down in share market and share value of the product. In that summer time the demand has decreased and the profit has slightly down. Normative: This criterion make use of the judgment, what ought to be the level of performance to classify and element as a strength or a weakness?. Based on industrial practices and personal opinion, norms for evaluation can be developed. The research and development has continuous growth of new product and in 2008 the revenue is $31.5 billion. So if the process of new product stage is declining in the research, then it will be says as weakness. The AstraZeneca company has continuous process of new product. It has a sustainable environment to market their product to the customer. AstraZeneca has come across number of new products and medicines for the cancer, cardiovascular, intestine etc.. Competitive Parity: This criterion was the action of successful competitors or potential competitors. The new medicines are produced by the usage of drugs and some other agri-products. The drugs must used in a certain level. It should not go beyond of the level of drugs in to medicines. The new product will be in quality conscious. Critical factor for Success: Each business is unique and has a set of minimum objectives (i.e) to improve their drugs pipeline and they can set minimum factors of medicine, which should give more effective to the patients. So they are the strength of the company. The critical factors are considered in the pharmaceutical industry and it has able to give continuous growth to the society. This will consider to over all strength to the resources of this pharmacy industry. Pearce, Strategic Management, PHI, 2006 (date: 12-01-2010, time: 3.15p.m) Strength and Weakness of the AstraZeneca Plc.: Internal Factors: Strength Weakness More research centres are in various countries. Brand Name Having skill, experience and quality of their researchers and lab staffs. Agricultural chemical industries are working towards it. Efficient development of R D investment. Key product Development Utilization of various technologies into the biological labs. Competitors are in world wide. The shareholder value is less when compare to other competitor. They invest $16 million to R D for every day to day work. They are dumping their investment to their research itself. Major competitor are Johnson Johnson, Pfize, Bayer, Abbot Laboratories etc.. In AstraZeneca Pharmaceutical industry has more strength of this company is, investment of research and development and continuous growth of new product development. The major weakness of AstraZeneca is a competitor. It has works over 100 countries around the world. so they are marketing their products in the International market. this pharmaceutical industry has compete their compete their competitor by the way of merging their industry. AstraZeneca is a largest pharmaceutical company in the world. The market has more competitors in pharmacy industry. The major competitor are Johnson Johnson, Bayer, Pfize, Novarties, Abbot Laboratories etc.. AstraZeneca has sustained their product by producing new product and medicines by the activity of research and development. http://www.ingentaconnect.com/content/fm/pme/2006/00000003/00000002/art00009 (date: 12-01-2010, time: 3.45p.m) Research and Development is a strong basement to this AstraZeneca pharmaceutical industry. They are investing around $ 5 billion in 2008, for the research and development activities. They are actively participated in improving drugs pipeline and they aim to achieve major great medicines in 2010. They are launches two new molecular Entity to the develop their new medicines. Attribute measures of its strength and weakness: These refer to statements developed to identify or list a characteristic or quality, an organization possesses or likely to possess in the near future. Our key strength is the having sustainable growth in new products development in the R D department. Our key weakness is investing more money to research and Development. Here the strength is the research and development has a innovation of new product and development in a biological industry. But at the same time the weakness is to investing more money to the R D. AstraZeneca has dumping their money to R D centre rather than other department. So it should balance the investment to other business and other factor. But at the same time, it should concentrate is R D to improve new drug pipeline. Implementing Porters competitive strategies: It should compete on the basis of low cost, or should us different our medicines on some basis other than cost, such as quality or service. It should we compete head to head with our major competitors for the biggest but most sought after share of the market. The porters competitive strategies are based on the Lower cost strategy and Differentiation strategy. Lower cost strategy is followed by this pharmaceutical company, it has an ability to design, produce, and market a comparable product more efficiently than its competitors. Differentiation Strategy is focused the company, it ability to provide unique and superior value to the buyer in terms of product quality, special features, or after-sales service. The competitive strategies are followed by different types by the way of competitive advantage and competitive scope of the pharmaceutical company. The cost leadership is considered that the pharmaceutical company has aims to broad mass market and requires aggressive construction of efficient-scale facilities, vigorous pursuit of cost reductions from experience, tight cost and overhead control, avoidance of marginal customer accounts, and cost minimizing areas like R D, service, sales, force, advertising and so on. These companies have done in a marketing department and achieve its goal among competitors. Differentiation is aim to broad mass market and involves the creation of a product or service that is perceived throughout its industry as unique. This company has differentiated their product, medicines, its quality, technology, agri-products, and features of the medicines among other competitors. Cost focus is considered to focus the primary buyer group or geographic market and attempts to serve only this niche, to the exclusion of others. This company has focus the cancer, cardiovascular, gastrointestinal, infection neuroscience and respiratory and inflammation patients. They founded by hospital and they improve their quality services at the same time low cost to the patients, Differentiation Focus strategy is concentrates its particular buyer group, product line segment, or geographic market. AstraZeneca has manufacturing its different countries and it focus some diseases group, which cant get the medicine easily for particular disease. So it focus differentiated among the competitor. These are competitive strategies has adopting and implementing to the AstraZeneca Pharmaceutical industry. Neil Ritson, Strategic Management, PHI, 2006 (date: 12-01-2010, time: 4.35p.m) Analysis of AstraZeneca Plc: AstraZeneca has mostly focuses on their new medicines and their development. They are developing their new drugs pipeline for various diseases like cancer, cardiology etc., There are 19 research and Development centers are available at various countries also focuses in Social responsible activities and they are increases their stake holder value. The future investment of research and development and new product development must balance each other. From these analyses, this pharmaceutical company has more strength rather than the weakness. So the company has performed well in the past records. More strategy has adopted in the review. It should used in a marketing department and it should develp these strategies for marketing department. http://www.healthlinks-events-bpc2009.co.uk/presentations/brent_vose%20tues%208th%2011.25%20Astra%20Zeneca%20Plenary%20-challenges%20and%20oportunities.pdf (date: 12-01-2010, time: 5.25p.m) Recommendations: AstraZeneca the pharmaceutical industry has investing more money to research and development, it means to they are dumping their only to research itself. It must also consider the marketing department to improve their effective sales growth. The R D department must come across more drug pipeline diseases like swine flue, cancer, cardiovascular, gastro intestinal, infection, neuroscience and respiratory and inflammation. The R D must use more agri product rather than the chemicals. So it leads to more quality to the patients. The company must also focus to the marketing department because there is more competitors to this industry. The company must use marketing strategy effectively which are considered into this review. Conclusion: In this review we are concluded that the company has more strength rather than the weakness because of the research and development. In future market there is more medicines are all increased by the competitor. So it should consider improving the research and development by effective biological sciences, technologies and quality conscious of fit workers. The AstraZeneca has performing in social responsibilities to the society. In future it may increase the sustainable growth in new product development.

Wednesday, September 4, 2019

A Commentary on Mans Faith and his Guilt Essay -- Religion Religious

A Commentary on Man;s Faith and his Guilt Archibald MacLeish raised many thought provoking questions in the play J.B.. The Book of Job had already asked some of these questions, while others were very original and insightful. MacLeish offers many powerful thoughts on the relationship between man and God, some of which are disturbing to consider. Nickels lost his faith in both God and man. He believes that the purpose of life is merely to survive and not to live. Nickles says, There must be thousands!... Millions and millions of mankind burned, crushed, broken, mutilated, slaughtered, and for what? For thinking! For walking around the world in the wrong skin, the wrong shaped noises, eyelids: sleeping the wrong night wrong city- London, Dresden, Hiroshima. (MacLeish, 12) In fact the only thing that Nickels did have faith in was that J.B. would curse God if tested. Mr. Zuss, on the other hand, has complete faith in humanity and J.B. He knows of J.B.'s strength and his ability to love God. In short, Mr. Zuss has faith in J.B.'s faith. However, J.B.'s faith in God is ill founded. J.B.'s faith in God is based on the fact that he believes God to be just, but is God really just? If he is then why does J.B. suffer so? Maybe it is just J.B.'s notion of justice that is incorrect. Bildad comments on the notion of justice, "History is justice! -- Time inexorably turned to truth!… One man's suffering won't count, no matter what his suffering; but all will. At the end ...

Tuesday, September 3, 2019

Theropod Discovery Challenges the Dinosaur-to-Bird Theory :: Anthropology Essays Paleontology Papers

Theropod Discovery Challenges the Dinosaur-to-Bird Theory For years, it has been believed that Dinosaurs are ancestors of modern day birds. By simply looking at pictures of dinosaurs, one can find many physical similarities between these reptiles and modern day birds. Often the legs and the chest cavities are very similar in shape. Some dinosaurs have limbs that look like they could evolve into modern day wings, some dinosaurs even had feathers (6). A recent discovery in Italy of an extremely well preserved Scipionyx samniticus challenges this idea. The skeleton of this small Therapod was nearly complete, but more impressively, there was still remnants of soft tissue. Portions of the Trachea, the liver, the skeletal muscle, and the intestines were still preserved (1). Scipionyx is a small meat-eating dinosaur that lived in the early Cretaceous. It has sharp teeth and claws, with powerful hind legs. The fourth maxillary tooth is longer than the rest almost giving the Scipionyx a vampire-like look. It has a long tail that aided in its balance, very large eyes and was most likely a small, yet quick hunter (3). It lived in what is now Italy. The skeleton that was found was a nine inch newborn, but some scientists think that a full grown Scipionyx can reach up to ten feet in length (3). The Scipionyx also possess an enormous hand which is common to the maniraptors (3). This group includes dinosaurs like the velociraptor. The Scipionyx was so well preserved in limestone, that using an ultra-violet light, one could get almost an X-ray of the baby Therapod (5). The internal organs of this dinosaur are somewhat similar to that of a crocodile. For example, the Trachea is well situated in the vertebral column (1). In birds, the Tracheas is usually adjacent to the vertebral column. Similarly to the crocodile, the Scipionyx’s liver is placed ahead of the large intestine (1). The Scipionyx has small groups of muscle fibers that seem to be diaphragmatic musculature (1). Again, these are similar to that of modern day crocodiles. The diaphragmatic musculature aides in diaphragm assisted breathing, which allows modern-day crocodiles to have burst-like movements (1). These traits are not consistent with an avian style, air sac component which is typical of birds (1). The diaphragm was shown to divide the body into two parts. One part contained the heart and the lungs, the other had the intestines, and the entrails (2).

Monday, September 2, 2019

The NCLB Act Essay -- essays papers

The NCLB Act History The NCLB Act was created from initiatives originally introduced in the Elementary and Secondary School Act. The Elementary and Secondary School Act designed by then Commissioner of Education Francis Keppel and was passed on April 9, 1965. This was less than three months after the bill was first introduced. President Lyndon B. Johnson launched the 'War on Poverty' this being the most important educational component of the war. (Schugurensky, 2002) Through special funding this act allowed underprivileged and impoverished children a chance to receive education that met up to national standards. The special funding allotted more than 1 billion dollars to low income families to receive education that compared to affluent families. The Head Start program quickly grew out of this Act. In the Head Start program preschoolers received education that would prepare them for the challenges they would face in elementary schools the following year. (Amis, 2001) The ESEA was amended in 1968 to include the needs of children that had limited English speaking ability which eventually became the Bilingual Education Act. The NCLB presents a sweeping overhaul of federal efforts to support elementary and secondary education in the United States. The NCLB Act is built on four pillars, accountability for results, emphasis on doing what works, expanded parental options and expanded local controls and flexibility. (Toolkit, 2003) Standards criteria established by an educational institution to determine levels of student achievement.† (EBSCOhost Thesaurus) Each of these sets of standards may vary slightly state by state. A school that does not meet the criteria laid out by the state for two years running is labeled as n... ...n, L. S. and Owings, W. A. (May 2003) The Politics of Teacher Quality. Volume 84 pp. 687-92 Retrieved: May 1 2004 From: EBSCO Amis, K. (2001). Bush says reading is first. Thomas B. Fordham Foundation. Retrieved: Feb. 16 2004 from: www.edexcellence.net U.S. Department of Education (2004) No child left behind overview. U.S. Department of Education, Retrieved: Feb. 16, 2004 from: www.ed.gov What Works Clearinghouse (2002) Retrieved April 15 2004 from: www.w-w-c.org Schugurensky, D. (2002) History of Education Retrieved: April 22 2004 from: http://fcis.oise.utoronto.ca/~daniel_schugurensky/assignment1/1965elemsec.html (2003) The Elementary and Secondary Education Act in Washington An overview Retrieved: April 22 2004 from: http://www.k12.wa.us/ESEA/ U.S. Department of Education (2003) A Toolkit for Teachers. Washington DC: U.S. Government Printing Office

Sunday, September 1, 2019

Evaluate the Influence Different Stakeholders Exert in One Organisation

I am going to evaluate the influence that stakeholders exert on Zotefoams PLC. I will be evaluating the following stakeholders: customers, employees, shareholders, suppliers, the government and owners. Customers Customers contribute to profit levels and turnover through buying products and services. People are stakeholders in a company for financial reasons; customers do not want to have to spend an excessive amount of money to purchase a product, so if one of Zotefoams competitors can produce the same product for a lower price the customer may be tempted to change suppliers.Without its customer Zotefoams would not exist, they survive through customer loyalty and their ability to attract new custom. To ensure that they get regular customers Zotefoams ensures that all of its products are the best on the market. Customer service is also held very highly. By offering these incentives Zotefoams are getting regular customers which bring in more profit which then can be used to help expand the business.In the resent economic down-turn Zotefoams business customers have been demanding cheaper products, and with the risk of losing contacts worth millions of pounds Zotefoams has had to expand its manufacturing base with factories in the UK, USA and now in China. This diversity allows them created not only cheaper products but also more specialised one too. This has opened up a larger market for them which have increased their share prices by 50% in two years. This has all been brought on by the need to satisfy their existing customer and increase their potential one.Employees Employee is any person hired by an employer to do a specific job. Employees are important as any other stakeholder because they have first contact with customers so if the customers want to ask a question about the organisation or about a product then the employees can help with that and that employees could also recommend products to customers which will bring in more profit. Employees must know ab out the customer service policy. If customers have a problem or an issue with a product or service then employees must know how to deal with it.Zotefoams have business and public customer that require different levels of customer service. The advantage to having a customer service for the customers is that their needs and complaints will be responded to. In reality, there are several factors that influence how committed employees are to a company or organization. It has been proven that the more autonomy and responsibility that a job has, the less repetitive and dull that job also is and the more likely the worker is to enjoy and feel satisfied by the work.Those individuals who feel stimulated, challenged and satisfied in their jobs are much more likely to be committed to a given work environment, company or organisation. Additionally, things like promotional opportunities, pay raises and chances for cross-training and advancement all encourage commitment. Those jobs or companies wh ere there are fewer opportunities for promotion, advancement, and education tend to have higher turnover and less satisfied employees. In essence it is a very symbiotic relationship.A business such as Zotefoams needs to employee a number of skilled employees to reach its business goals and likewise skilled employees would have the advantage of having a larger amount of employers to choose from. As a result the amount of influence employees have on a business is only (in my option) second to a business’s customer. Shareholders Shareholders are the owners of a company. They have the potential to profit if the company does well, but that comes with the potential to lose if the company does poorly. Shareholders can influence a business in many ways.They can exert their influence by voting for particular directors or they can exert their influence by approving dividend payments at the AGM (Annual General Meeting). Shareholders play an important role in raising funds for organisati ons. So these figures create a great opportunity for all those who are looking for a profitable option to invest money. The main powers of the Annual General Meeting of shareholders are to approve and receive dividend proposals. An AGM (Annual General Meeting) is a meeting that official bodies and ssociations involving the public including companies with shareholders are often required by law to hold.An AGM is held every year to elect the Board of Directors and inform their members of previous and future activities. It is an opportunity for the shareholders and partners to receive copies of the company's accounts as well as reviewing financial information for the past year and asking any questions regarding the directions the business will take in the future. In reality (a company such as Zotefoams) the shareholders have little or no impact on virtually anything to do with the company.Most companies have millions of shares outstanding and thousands of shareholders. The management ge nerally makes all strategic decisions unless the decision involves raising funds through bonds or secondary offerings, along with potential mergers or acquisitions. Issues of that significance are presented to the Board of Directors by the management and decided by the Board. In general, management considers shareholders simply as investors, and that the shareholders are only concerned about the share price or dividend payout.They know that it is virtually impossible for general shareholders to get 50% + 1 to change the board. That is not to say the company does not care about the shareholders. It simply assumes that the board and top management know the most about the company and therefore will automatically do what they believe is in the best interest for both the company and investor. External stakeholders-Suppliers Stock managers have trusted suppliers to supply them with the products they need to sell.The suppliers should provide the products on time, however if not then stock managers will find new suppliers that are better than the ones they had previously. If stock managers and suppliers have a good relationship with one another then they would be happy to work with each other which means stock managers will have a reliable source of supplies and suppliers will have a reliable source of income. If suppliers are happy then they will be more motivated to help the business to achieve success and help the business run effectively. Suppliers must supply the stock managers with good quality products.If however the products are bad quality then stock managers will find new suppliers and their previous suppliers will lose customers and they would get a bad reputation which means all their other customers will find new suppliers too. Zotefoams suppliers influence the business by making sure they have the right amount of stock delivered at the right time. If their suppliers do not supply high quality goods this would be a disadvantage. This could lead to a reduc tion of customers. The Government The government sets corporate tax rates for businesses so that they pay their taxes.This way, a business can make its contribution towards the society. As a result, the government uses this money for economic growth and development. Paying taxes help these businesses to streamline their processes, as a result of more efficient infrastructure and management. The taxes paid also assist in supporting backward countries, so that overall demand of their products is not only restrained to UK, but includes exports to these nations too. Government laws are there to handle disputes, errors or poor judgment of a given person.In any society, disagreement between employees can break down a healthy structure, so the laws are in place to attempt to guarantee equal rights to each member. Conclusion My conclusion is that there are a number of different stakeholders that hold different levels of influences on Zotefoams. But in my option out of all of Zotefoams (or a ny business) stakeholders its customer would hold the most influence, because after all a business cannot operate without its customers. By looking at a number of case studies (1) you can see a direct link between poor PR/ customer service and a company stock prices and sales.In November 2011 Shares of Abercrombie & Fitch plunged more than 15% in one day resulting from a PR disaster. This is evidences that if a company do not reflect the wishes of its customer or delivers poor service/goods there can be a massive negative effect on the business. Another example of how customers can effect business operations is the disastrous speech made by CEO Gerald Ratner of The Ratner Group. After making a speech in which he jokingly denigrated the company's products as â€Å"tacky† he nearly caused the company's near collapse. The company’s stakeholders are very important to keep the business up and running.A company’s stakeholders are all important but in handling its stak eholders, a business also has to accept that it will have to make choices. It is rare that â€Å"win-win† solutions can be found for key business decisions. Almost certainly the business cannot meet the needs of every stakeholder group and most decisions will end up being â€Å"win-lose†: i. e. supporting one stakeholder means another misses out. There are often areas where stakeholder interests are aligned, where a decision can benefit more than one stakeholder group. In other cases, there is a clear conflict of interest.